1,100
Participants
Start Date
December 31, 2003
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2005
Roflumilast
ALTANA Pharma, Cities in Alabama
ALTANA Pharma, Cities in Arizona
ALTANA Pharma, Cities in Arkansas
ALTANA Pharma, Cities in California
ALTANA Pharma, Cities in Colorado
ALTANA Pharma, Cities in Connecticut
ALTANA Pharma, Cities in Florida
ALTANA Pharma, Cities in Georgia
ALTANA Pharma, Cities in Illionois
ALTANA Pharma, Cities in Iowa
ALTANA Pharma, Cities in Kentucky
ALTANA Pharma, Cities in Louisiana
ALTANA Pharma, Cities in Massachusetts
ALTANA Pharma, Cities in Minnesota
ALTANA Pharma, Cities in Missouri
ALTANA Pharma, Cities in Montana
ALTANA Pharma, Cities in Nebraska
ALTANA Pharma, Cities in Nevada
ALTANA Pharma, Cities in New Hampshire
ALTANA Pharma, Cities in New Jersey
ALTANA Pharma, Cities in New York
ALTANA Pharma, Cities in North Carolina
ALTANA Pharma, Cities in Ohio
ALTANA Pharma, Cities in Oklahoma
ALTANA Pharma, Cities in Oregon
ALTANA Pharma, Cities in Pennsylvania
ALTANA Pharma, Cities in Rhode Island
ALTANA Pharma, Cities in South Carolina
ALTANA Pharma, Cities in Tennessee
ALTANA Pharma, Cities in Texas
ALTANA Pharma, Cities in Utah
ALTANA Pharma, Cities in Vermont
ALTANA Pharma, Cities in Virginia
ALTANA Pharma, Cities in West Virginia
ALTANA Pharma, Cities in Wisconsin
ALTANA Pharma, Cities in Canada
ALTANA Pharma, Cities in France
ALTANA Pharma, Cities in Germany
ALTANA Pharma, Cities in Poland
ALTANA Pharma, Cities in South Africa
Lead Sponsor
AstraZeneca
INDUSTRY